| Profile | GDS5420 / 235122_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 434.48 | 65 |
| GSM1296119 | B_lesional_pre-dose | 245.23 | 55 |
| GSM1296076 | C_lesional_pre-dose | 231.61 | 56 |
| GSM1296092 | D_lesional_pre-dose | 526.18 | 69 |
| GSM1296103 | E_lesional_pre-dose | 543.9 | 69 |
| GSM1296078 | F_lesional_pre-dose | 248.99 | 58 |
| GSM1296107 | G_lesional_pre-dose | 226.47 | 54 |
| GSM1296109 | H_lesional_pre-dose | 314.27 | 59 |
| GSM1296080 | I_lesional_pre-dose | 1062.44 | 80 |
| GSM1296090 | J_lesional_pre-dose | 450.73 | 66 |
| GSM1296074 | K_lesional_pre-dose | 520.26 | 69 |
| GSM1296111 | L_lesional_pre-dose | 216.41 | 53 |
| GSM1296099 | M_lesional_pre-dose | 216.19 | 53 |
| GSM1296086 | O_lesional_pre-dose | 505.23 | 68 |
| GSM1296117 | P_lesional_pre-dose | 203.08 | 52 |
| GSM1296113 | Q_lesional_pre-dose | 384.25 | 63 |
| GSM1296096 | R_lesional_pre-dose | 208.56 | 53 |
| GSM1296105 | S_lesional_pre-dose | 251.16 | 55 |
| GSM1296098 | T_lesional_pre-dose | 504.57 | 68 |
| GSM1296101 | U_lesional_pre-dose | 253.19 | 56 |
| GSM1296121 | V_lesional_pre-dose | 212.54 | 53 |
| GSM1296088 | W_lesional_pre-dose | 417.29 | 65 |
| GSM1296082 | X_lesional_pre-dose | 300.97 | 60 |
| GSM1296115 | Y_lesional_pre-dose | 193.93 | 51 |
| GSM1296084 | Z_lesional_pre-dose | 427.4 | 65 |
| GSM1296072 | B_lesional_day8 | 314.73 | 59 |
| GSM1296069 | L_lesional_day8 | 243.11 | 54 |
| GSM1296071 | P_lesional_day8 | 197.14 | 50 |
| GSM1296070 | Y_lesional_day8 | 179.32 | 49 |
| GSM1296073 | V_lesional_day8 | 252.23 | 57 |
| GSM1296034 | A_lesional_day15 | 1111.54 | 81 |
| GSM1296041 | G_lesional_day15 | 196.52 | 52 |
| GSM1296035 | R_lesional_day15 | 308.39 | 59 |
| GSM1296038 | U_lesional_day15 | 147.61 | 47 |
| GSM1296047 | B_lesional_day15 | 352.08 | 61 |
| GSM1296039 | E_lesional_day15 | 271.03 | 58 |
| GSM1296042 | H_lesional_day15 | 260.5 | 56 |
| GSM1296043 | L_lesional_day15 | 200.66 | 51 |
| GSM1296037 | M_lesional_day15 | 402.5 | 64 |
| GSM1296046 | P_lesional_day15 | 191.77 | 50 |
| GSM1296044 | Q_lesional_day15 | 545.51 | 69 |
| GSM1296045 | Y_lesional_day15 | 240.58 | 54 |
| GSM1296025 | C_lesional_day15 | 873.31 | 77 |
| GSM1296033 | D_lesional_day15 | 564.16 | 69 |
| GSM1296027 | I_lesional_day15 | 1981.8 | 88 |
| GSM1296032 | J_lesional_day15 | 1187.7 | 82 |
| GSM1296024 | K_lesional_day15 | 1295.85 | 83 |
| GSM1296031 | W_lesional_day15 | 672.24 | 72 |
| GSM1296028 | X_lesional_day15 | 792.13 | 75 |
| GSM1296029 | Z_lesional_day15 | 577.3 | 70 |
| GSM1296026 | F_lesional_day15 | 420.49 | 65 |
| GSM1296030 | O_lesional_day15 | 1291.72 | 82 |
| GSM1296040 | S_lesional_day15 | 261.92 | 57 |
| GSM1296036 | T_lesional_day15 | 723.76 | 74 |
| GSM1296048 | V_lesional_day15 | 365.9 | 62 |
| GSM1296059 | A_lesional_day43 | 370.64 | 63 |
| GSM1296066 | G_lesional_day43 | 237.49 | 54 |
| GSM1296060 | R_lesional_day43 | 234.7 | 55 |
| GSM1296063 | U_lesional_day43 | 194.88 | 52 |
| GSM1296064 | E_lesional_day43 | 303.92 | 60 |
| GSM1296067 | H_lesional_day43 | 360.25 | 61 |
| GSM1296062 | M_lesional_day43 | 663.47 | 72 |
| GSM1296068 | Q_lesional_day43 | 468.63 | 66 |
| GSM1296050 | C_lesional_day43 | 356.69 | 62 |
| GSM1296057 | D_lesional_day43 | 486.6 | 67 |
| GSM1296052 | I_lesional_day43 | 1794.06 | 87 |
| GSM1296054 | J_lesional_day43 | 1271.48 | 83 |
| GSM1296049 | K_lesional_day43 | 800.91 | 75 |
| GSM1296055 | W_lesional_day43 | 211.51 | 52 |
| GSM1296053 | X_lesional_day43 | 809.16 | 75 |
| GSM1296058 | Z_lesional_day43 | 281.66 | 58 |
| GSM1296051 | F_lesional_day43 | 286.78 | 59 |
| GSM1296056 | O_lesional_day43 | 265.38 | 58 |
| GSM1296065 | S_lesional_day43 | 235.24 | 55 |
| GSM1296061 | T_lesional_day43 | 936.98 | 78 |
| GSM1296095 | A_non-lesional_pre-dose | 306.41 | 60 |
| GSM1296120 | B_non-lesional_pre-dose | 433.16 | 65 |
| GSM1296077 | C_non-lesional_pre-dose | 942.21 | 78 |
| GSM1296093 | D_non-lesional_pre-dose | 1100.81 | 81 |
| GSM1296104 | E_non-lesional_pre-dose | 305.26 | 59 |
| GSM1296079 | F_non-lesional_pre-dose | 590.37 | 71 |
| GSM1296108 | G_non-lesional_pre-dose | 264.3 | 56 |
| GSM1296110 | H_non-lesional_pre-dose | 394.31 | 63 |
| GSM1296081 | I_non-lesional_pre-dose | 2096.45 | 89 |
| GSM1296091 | J_non-lesional_pre-dose | 1095.87 | 80 |
| GSM1296075 | K_non-lesional_pre-dose | 648.55 | 72 |
| GSM1296112 | L_non-lesional_pre-dose | 259.17 | 55 |
| GSM1296100 | M_non-lesional_pre-dose | 430.39 | 65 |
| GSM1296087 | O_non-lesional_pre-dose | 1352.75 | 83 |
| GSM1296118 | P_non-lesional_pre-dose | 508.76 | 67 |
| GSM1296114 | Q_non-lesional_pre-dose | 575.37 | 70 |
| GSM1296097 | R_non-lesional_pre-dose | 158.13 | 48 |
| GSM1296106 | S_non-lesional_pre-dose | 388 | 63 |
| GSM1296102 | U_non-lesional_pre-dose | 416.11 | 64 |
| GSM1296122 | V_non-lesional_pre-dose | 277.73 | 57 |
| GSM1296089 | W_non-lesional_pre-dose | 591.57 | 70 |
| GSM1296083 | X_non-lesional_pre-dose | 1125.23 | 81 |
| GSM1296116 | Y_non-lesional_pre-dose | 302.72 | 58 |
| GSM1296085 | Z_non-lesional_pre-dose | 887.99 | 77 |